Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort

Gastroenterology

Volumn 117, Issue 1, 1999, Pages 49-57

  Silverstein, M D ^a   Loftus E V , Jr ^a   Sandborn, W J ^a   Tremaine, W J ^a   Feagan, B G ^a   Nietert, P J ^a   Harmsen, W S ^a   Zinsmeister, A R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; COLON SURGERY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; COST BENEFIT ANALYSIS; CROHN DISEASE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME;

EID: 0033022146     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70549-4     Document Type: Article

References (21)

1. DB Sachar HA Andrews RG Farmer F Pallone AS Pena C Prantera P Rutgeerts Proposed classification of patient subgroups in Crohn's disease Gastroenterol Int 5 1992 141 154
2. RG Farmer G Whelan VW Fazio Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis Gastroenterology 88 1985 1818 1825
3. AJ Greenstein P Lachman DB Sachar J Springhorn T Heimann HD Janowitz AH Aufses Jr Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms Gut 29 1988 588 592
4. P Munkholm E Langholz M Davidsen V Binder Frequency of glucocorticoid resistance and dependency in Crohn's disease Gut 35 1994 360 362
5. JR Beck SG Pauker The Markov process in medical prognosis Med Dec Mak 3 1983 419 458
6. MD Silverstein DA Albert NM Hadler MW Ropes Prognosis in SLE: comparison of Markov model to life table analysis J Clin Epidemiol 41 1988 623 633
7. P Munkholm E Langholz M Davidsen V Binder Disease activity courses in a regional cohort of Crohn's disease patients Scand J Gastroenterol 30 1995 699 706
8. LJ 3 Melton History of the Rochester Epidemiology Project Mayo Clin Proc 71 1996 266 274
9. LT Kurland CA Molgaard The patient record in epidemiology Sci Am 245 1981 54 63
10. JH Gollop SF Phillips LJ Melton III AR Zinsmeister Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943–1982 Gut 29 1988 49 56
11. EV Loftus Jr MD Silverstein WJ Sandborn WJ Tremaine WS Harmsen AR Zinsmeister Crohn's disease in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival Gastroenterology 114 1998 1161 1168
12. JD Klabfleisch JF Lawless The analysis of panel data under a Markov assumption J Am Stat Assoc 80 1985 863 871
13. SA Finkler The distinction between cost and charges Ann Intern Med 96 1982 102 109
14. A Ekbom CG Helmick M Zack L Holmberg HO Adami Survival and causes of death in patients with inflammatory bowel disease: a population-based study Gastroenterology 103 1992 954 960
15. PG Persson O Bernell CE Leijonmarck BY Farahmand G Hellers A Ahlbom Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study Gastroenterology 110 1996 1339 1345
16. E Langholz P Munkholm M Davidsen V Binder Course of ulcerative colitis: analysis of changes in disease activity over years Gastroenterology 107 1994 3 11
17. AR Hay JW Hay Inflammatory bowel disease: medical cost algorithms J Clin Gastroenterol 14 1992 318 327
18. JW Hay AR Hay Inflammatory bowel disease: costs-of-illness J Clin Gastroenterol 14 1992 309 317
19. SE Gabriel CS Crowson ME Campion WM O'Fallon Direct medical costs unique to people with arthritis J Rheumatol 24 1997 719 725
20. P Blomqvist A Ekbom Inflammatory bowel diseases: health care and costs in Sweden in 1994 Scand J Gastroenterol 32 1997 1134 1139
21. C Camma M Giunta M Rosselli M Cottone Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables Gastroenterology 113 1997 1465 1473